Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies

Abroad (travel likely)Recruiting

Conditions

Influenza · Respiratory Virus · Coronavirus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) · prpl@cc.nih.gov · 800-411-1222

Study leads

Luca T Giurgea, M.D.
Principal Investigator
National Institute of Allergy and Infectious Diseases (NIAID)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

Influenza Prevention · Seasonal Influenza

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States

Screening for LID Clinical Studies Unit Healthy Volunteer Protocols

Zika · Influenza

Abroad (travel likely)Recruiting

Bethesda, United States

A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

Influenza, Human+COVID-19

Abroad (travel likely)RecruitingPHASE1

Anniston, United States · Little Rock, United States

Effectiveness and Implementation of a National Guideline for Acute Respiratory Tract Infections to Reduce Antibiotic Prescribing in Swiss Primary Care

Acute Respiratory Infection · Influenza-like Illness

Abroad (travel likely)Recruiting

Lausanne, Switzerland